US 2008/0085280 A1Published application

Monovalent ligand of the Fcalphari Receptor as an Anti-Inflammatory Agent

AssigneeInstitut National de la Sante et de la Recherche

InventorsRenato Monteiro, Benoit Pasquier, Ulrich Blank, Marc Benhamou, Pierre Launay, Marina Pretolani

Life of this patent

Estimating the term…

Abstract

The invention relates to the use of a monovalent antibody fragment directed against the EC2 domain of the FcαRI receptor for the treatment of inflammatory diseases.

Claims22

Dependent claims

1-4. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 10/591,642Filed 4 Mar 2005
Priority: EP 04290615.65 Mar 2004
Published: 10 Apr 2008
Term ends: Not estimatedThe source records don’t support an estimate.

Classification20 codes

C07K 16/283
Against the immunoglobulin superfamily: against Fc-receptors, e.g. CD16, CD32, CD64
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system
A61P 3/10
For glucose homeostasis: for hyperglycaemia, e.g. antidiabetics
A61P 7/12
Drugs for disorders of the blood or the extracellular fluid: antidiuretics, e.g. drugs for diabetes insipidus

Family

US 7,892,538 B2Related patent
US 2008/0085280 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…